We are live on
!
Find out more
ABVX
Abivax
ABVX
ABVX
254 hedge funds and large institutions have $5.53B invested in Abivax in 2026 Q1 according to their latest regulatory filings, with 53 funds opening new positions, 111 increasing their positions, 75 reducing their positions, and 43 closing their positions.
New
Increased
Maintained
Reduced
Closed
63% more call options, than puts
Call options by funds: $233M | Put options by funds: $142M
48% more repeat investments, than reductions
Existing positions increased: 111 | Existing positions reduced: 75
23% more first-time investments, than exits
New positions opened: 53 | Existing positions closed: 43
3% more funds holding
Funds holding: 247 → 254 (+7)
9.05% less ownership
Funds ownership: 72.25% → 63.2% (-9%)
18% less funds holding in top 10
Funds holding in top 10: 34 → 28 (-6)
27% less capital invested
Capital invested by funds: $7.61B → $5.53B (-$2.08B)
Holders
254
Holders Change
+7
Holders Change %
+2.83%
% of All Funds
3.13%
Holding in Top 10
28
Holding in Top 10 Change
-6
Holding in Top 10 Change %
-17.65%
% of All Funds
0.34%
New
53
Increased
111
Reduced
75
Closed
43
Calls
$233M
Puts
$142M
Net Calls
+$90.2M
Net Calls Change
-$23M
Top Buyers
Top Sellers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$210M |
| 2 |
Morgan Stanley
New York
|
-$171M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$103M |
| 4 |
PBA
Paradigm Biocapital Advisors
New York
|
-$76.3M |
| 5 |
TCM
TCG Crossover Management
Palo Alto,
California
|
-$74.6M |
